Company news
CRISPR Therapeutics AG news in 2019
CRISPR Therapeutics AG's news releases, calls and decks from 2019, newest first.
CRISPR Therapeutics to Present at Upcoming Investor Conferences
November 26, 2019
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
November 18, 2019
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
November 18, 2019
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
October 27, 2019
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
October 14, 2019
CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019
September 16, 2019
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia
April 15, 2019
Decks in 2019
- Technical Presentation (November 2019)
Technical · 13 slides · Nov 19, 2019